Nephrogenic adenoma: An update on an innocuous but troublesome entity

Advances in Anatomic Pathology

Volumn 13, Issue 5, 2006, Pages 247-255

  Rahemtullah, Aliyah ^a   Oliva, Esther ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Clear cell carcinoma; Differential diagnosis; Immunohistochemistry; Nephrogenic adenoma; Pathogenesis; Prostatic adenocarcinoma; Urothelial carcinoma; Urothelium

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ALKALINE PHOSPHATASE; CA 125 ANTIGEN; CA 19-9 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; KI 67 ANTIGEN; LECTIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53; PROTEIN P63; PROTEIN S 100; TRANSCRIPTION FACTOR PAX2;

ADENOMA; CLEAR CELL CARCINOMA; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ELECTRON MICROSCOPY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; MICROSCOPY; NEPHROGENIC ADENOMA; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; REVIEW; SIGNET RING CARCINOMA; STROMA; UROGENITAL TRACT TUMOR; UROTHELIUM;

ADENOCARCINOMA, CLEAR CELL; ADENOMA; CARCINOMA, SIGNET RING CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 33748977494     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/01.pap.0000213047.69564.c2     Document Type: Review

References (64)

1. Davis TA. Hamartoma of the urinary bladder. Northwest Med. 1949;48:182-185.
2. Friedman NB, Kuhlenbeck H. Adenomatoid tumors of the bladder reproducing renal structures (nephrogenic adenomas). J Urol. 1950;64:657.
3. Ford TF, Watson GM, Cameron KM. Adenomatous metaplasia (nephrogenic adenoma) of urothelium. An analysis of 70 cases. Br J Urol. 1985;57:427-433.
4. Husain AN, Armin AR, Schuster GA. Nephrogenic metaplasia of urinary tract in children: report of three cases and review of the literature. Pediatr Pathol. 1988;8:293-300.
5. Bernado L, Serrano A, Vidal MT. Nephrogenic metaplasia of the ureter. Pediatr Pathol. 1986;5:389-395.
6. Young RH, Scully RE. Nephrogenic adenoma. A report of 15 cases, review of the literature, and comparison with clear cell adenocarcinoma of the urinary tract. Am J Surg Pathol. 1986;10:268-275.
7. Oliva E, Young RH. Nephrogenic adenoma of the urinary tract: a review of the microscopic appearance of 80 cases with emphasis on unusual features. Mod Pathol. 1995;8:722-730.
8. Gokaslan ST, Krueger JE, Albores-Saavedra J. Symptomatic nephrogenic metaplasia of ureter: a morphologic and immunohistochemical study of four cases. Mod Pathol. 2002;15:765-770.
9. Sakkas G, Simopoulou S, Zamparelou A, et al. Nephrogenic adenoma of the prostatic urethra in a patient treated with ESWL for a lower ureteral stone. Int Urol Nephrol. 2001;33:369-371.
10. Whang M, Katz L, Ongcapin E, et al. Nephrogenic adenomas occurring in a patient with simultaneous kidney-pancreas transplant. Urology. 2000;55:949.
11. Piper NY, Thompson IM. Large nephrogenic adenoma following transurethral resection of the prostate. J Urol. 1999;161:605.
12. Ashida S, Yamamoto A, Oka N, et al. Nephrogenic adenoma of the bladder in a chronic hemodialysis patient. Int J Urol. 1999;6:208-210.
13. Tse V, Khadra M, Eisinger D, et al. Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases. Urology. 1997;50:690-696.
14. Fournier G, Menut P, Moal MC, et al. Nephrogenic adenoma of the bladder in renal transplant recipients: a report of 9 cases with assessment of deoxyribonucleic acid ploidy and long-term followup. J Urol. 1996;156:41-44.
15. Ducrocq S, Bruniau A, Cordonnier C, et al. Bladder nephrogenic metaplasia: circumstances of discovery, predisposing factors, and clinical course in 7 cases diagnosed between 1988 and 2000. Prog Urol. 2003;13:613-617.
16. Peeker R, Aldenborg F, Fall M. Nephrogenic adenoma - a study with special reference to clinical presentation. Br J Urol. 1997;80:539-542.
17. Kilciler M, Tan O, Ozgok Y, et al. Nephrogenic adenoma of the bladder after intravesical bacillus Calmette-Guerin treatment. Urol Int. 2000;64:229-232.
18. Goldman HB, Dmochowski RR, Noe HN. Nephrogenic adenoma occurring in an augmented bladder. J Urol. 1996;155:1410.
19. Redondo Martinez E, Rey Lopez A. Nephrogenic adenoma in intestinal mucosa. A case in urethro-sigmoid anastomosis. Arch Esp Urol. 1998;51:284-286.
20. Strand WR, Alfert HJ. Nephrogenic adenoma occurring in an ileal conduit. J Urol. 1987;137:491-492.
21. Banyai-Falger S, Maier U, Susani M, et al. High incidence of nephrogenic adenoma of the bladder after renal transplantation. Transplantation. 1998;65:511-514.
22. Pycha A, Mian C, Reiter WJ, et al. Nephrogenic adenoma in renal transplant recipients: a truly benign lesion? Urology. 1998;52:756-761.
23. Gonzalez JA, Watts JC, Alderson TP. Nephrogenic adenoma of the bladder: report of 10 cases. J Urol. 1988;139:45-47.
24. Beaudry C, Bertrand PE, Laplante L, et al. Nephrogenic adenoma of the bladder after kidney transplantation: spontaneous improvement with azathioprine removal; surgical trauma and cytomegalovirus infection as possible etiologic factors. J Urol. 1983;130:1183-1185.
25. Hung SY, Tseng HH, Chung HM. Nephrogenic adenoma associated with cytomegalovirus infection of the ureter in a renal transplant patient: presentation as ureteral obstruction. Transplant Int. 2001;14:111-114.
26. Redman JF, Parham DM. Calculus-producing and cytomegalovirus-infected nephrogenic adenoma of the bladder in a prepubertal renal transplant recipient. Urology. 2000;56:508.
27. Mazal PR, Schaufler R, Altenhuber-Muller R, et al. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients. N Engl J Med. 2002;347:653-659.
28. Ingelfinger JR. Nephrogenic adenomas as renal tubular outposts. N Engl J Med. 2002;347:684-686.
29. Tong GX, Melamed J, Mansukhani M, et al. PAX2: a reliable marker for nephrogenic adenoma. Mod Pathol. 2006;19:356-363.
30. Gupta A, Wang HL, Policarpio-Nicolas ML, et al. Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma. Am J Surg Pathol. 2004;28:1224-1229.
31. Xiao GQ, Burstein DE, Miller LK, et al. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma. Arch Pathol Lab Med. 2006;130:805-810.
32. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8:494-501.
33. Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2001;116:823-830.
34. Skinnider BF, Oliva E, Young RH, et al. Expression of alphamethlacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Am J Surg Pathol. 2004;26:701-705.
35. Bhagavan BS, Tiamson EM, Wenk RE, et al. Nephrogenic adenoma of the urinary bladder and urethra. Hum Pathol. 1981;12:907-916.
36. Dabbs D. Diagnostic Immunohistochemistry. 2nd ed. Philadelphia: Churchill Livingstone Elsevier; 2006:599-601.
37. Loy TS, Quesenberry JT, Sharp SC. Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases. Am J Clin Pathol. 1992;98:175-179.
38. Oliva E, Moch H, Cabrera R, et al. Nephrogenic adenoma (NA): an immunohistochemical (IHC) study of 40 cases (abstract). Mod Pathol. 2003;16:164A.
39. Kuehn A, Cohen C, Radhakrishnan B, et al. Expression of kidney-specific cadherin (KSP-CAD) in rare and unusual renal epithelial neoplasms. Diagnostic and histogenetic implications. Mod Pathol. 2006. In press.
40. Medeiros LJ, Young RH. Nephrogenic adenoma arising in urethral diverticula. A report of five cases. Arch Pathol Lab Med. 1989;113:125-128.
41. Cheng L, Cheville JC, Sebo TJ, et al. Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion? Cancer. 2000;88:853-861.
42. Allan CH, Epstein JI. Nephrogenic adenoma of the prostatic urethra: a mimicker of prostate adenocarcinoma. Am J Surg Pathol. 2001;25:802-808.
43. Gilcrease MZ, Delgado R, Vuitch F, et al. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Hum Pathol. 1998;29:1451-1456.
44. Malpica A, Ro JY, Troncoso P, et al. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases. Hum Pathol. 1994;25:390-395.
45. Devine P, Ucci AA, Krain H, et al. Nephrogenic adenoma and embryonic kidney tubules share PNA receptor sites. Am J Clin Pathol. 1984;81:728-732.
46. Wiener HG, Remkes GW, Birner P, et al. DNA profiles and numeric histogram classifiers in nephrogenic adenoma. Cancer. 2002;96:117-122.
47. Gaylis FD, Keer HN, Bauer KD, et al. DNA profile of nephrogenic adenoma assessed by flow cytometry. Urology. 1993;41:160-161.
48. Oliva E, Amin MB, Jimenez R, et al. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol. 2002;26:190-197.
49. Young RH, Scully RE. Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature. Am J Surg Pathol. 1985;9:816-826.
50. Alsanjari N, Lynch MJ, Fisher C, et al. Vesical clear cell adenocarcinoma. V. Nephrogenic adenoma: a diagnostic problem. Histopathology. 1995;27:43-49.
51. Hartmann A, Junker K, Dietmaier W, et al. Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma. Hum Pathol. 2006;37:117-120.
52. Lukkarinen O, Autio-Harmainen H. Nephrogenic adenoma of the bladder. Ann Chir Gynaecol. 1988;77:45-46.
53. Talbert ML, Young RH. Carcinomas of the urinary bladder with deceptively benign-appearing foci: a report of three cases. Am J Surg Pathol. 1989;13:374-381.
54. Young RH, Zukerberg LR. Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases. Am J Clin Pathol. 1991;96:635-639.
55. Lin O, Cardillo M, Dalbagni G, et al. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases. Mod Pathol. 2003;16:1289-1298.
56. Drew PA, Furman J, Civantos F, et al. The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol. 1996;9:989-994.
57. Murphy WM, Deana DG. The nested variant of transitional cell carcinoma: a neoplasm resembling proliferation of Brunn's nests. Mod Pathol. 1992;5:240-243.
58. Xiao GQ, Savage SJ, Gribetz ME, et al. The nested variant of urothelial carcinoma: clinicopathology of 2 cases. Arch Pathol Lab Med. 2003;127:e333-e336.
59. Volmar KE, Chan TY, De Marzo AM, et al. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma. Am J Surg Pathol. 2003;27:1243-1252.
60. Young RH. Nephrogenic adenomas of the urethra involving the prostate gland: a report of two cases of a lesion that may be confused with prostatic adenocarcinoma. Mod Pathol. 1992;5:617-620.
61. Daroca JPJ, Martin AA, Reed RJ, et al. Urethral nephrogenic adenoma. A report of three cases, including a case with infiltration of the prostatic stroma. J Urol Pathol. 1993;1:157-172.
62. Goldstein NS. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol. 2002;117:471-477.
63. Herrera GA, Turbat-Herrera EA, Lott RL. S-100 protein expression by primary and metastatic adenocarcinomas. Am J Clin Pathol. 1988;89:168-176.
64. Loy TS, Sharp SC, Andershock CJ, et al. Distribution of CA 19-9 in adenocarcinomas and transitional cell carcinomas. An immunohistochemical study of 527 cases. Am J Clin Pathol. 1993;99:726-728.